Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway

Published:2023-08 Issue: Volume:952 Page:175808
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Chen Suwen,Sun Shangwen,Feng Yanan,Li Xiu,Yin Guoliang,Liang Pengpeng,Yu Wenfei,Meng Decheng,Zhang Xin,Liu Hongshuai,Zhang Fengxia^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference51 articles.

1. Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice;Akinrotimi;Hepatology,2017

2. NURR1 activation in skeletal muscle controls systemic energy homeostasis;Amoasii;Proc. Natl. Acad. Sci. U.S.A.,2019

3. Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: results from two early-phase randomized trials;Beysen;Diabetes Obes. Metabol.,2021

4. Short communication: characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids;Bionaz;J. Dairy Sci.,2008

5. In vivo protective effects of diosgenin against doxorubicin-induced cardiotoxicity;Chen;Nutrients,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway;International Immunopharmacology;2024-09

2. Insights into diosgenin against inflammatory bowel disease as functional food based on network pharmacology and molecular docking;Heliyon;2024-09

3. The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications;Acta Pharmaceutica Sinica B;2024-08

4. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway;European Journal of Pharmacology;2024-08

5. Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease;npj Metabolic Health and Disease;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3